Managers’ transactions

May 25,2023 

Announcement no. 32 

Managers’ transactions 

Pharma Equity Group A/S has today received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transactions related to shares in Pharma Equity Group A/S made by persons discharging managerial responsibilities in Pharma Equity Group and/or persons closely related with them.   

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name	Thomas Kaas Selsø
2. Reason for the notification
a) Position/status	CEO
b) Initial notification/amendment	Initial notification
3. Details of the issuer
a) Name	Pharma Equity Group A/S
b) LEI	2138008SUI4D917FKN20
c) Trade name	PEG
4. Details of the transaction(s)
a) Description of the financial instrument, type    of instrument and Identification code	Shares, ISIN code DK0061155009
b) Nature of the transaction	Purchase
c) Price(s) and volume(s)	Price: DKK 167,225 Volume: 551,724
d) Aggregated information   - Aggregated volume   - Aggregated price	N/A
e) Date of the transaction	25-05-2023, 09:26 CEST
f) Place of the transaction	Nasdaq Copenhagen A/S

For further information, please contact:

Thomas Kaas Selsø, CEO of Pharma Equity Group A/S, phone: 40 22 21 14 

Peter M. Eriksen, Chair of the Board of Directors of Pharma Equity Group A/S, phone: 51 99 66 00. 

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.